A detailed history of Terril Brothers, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Terril Brothers, Inc. holds 5,245 shares of NVO stock, worth $254,172. This represents 0.1% of its overall portfolio holdings.

Number of Shares
5,245
Holding current value
$254,172
% of portfolio
0.1%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025

BUY
$45.38 - $71.7 $238,018 - $376,066
5,245 New
5,245 $291,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $109B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Terril Brothers, Inc. Portfolio

Follow Terril Brothers, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Terril Brothers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Terril Brothers, Inc. with notifications on news.